# Ping‐Chiao Tsai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ping-chiao-tsai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 272 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 6 |
| i10-index | 5 |
| Last Known Institution | Tzu Chi University |
| OpenAlex ID | https://openalex.org/A5038651665 |
| Works | 35 |

## Researcher papers

- [Ofatumumab demonstrates activity against rituximab‐sensitive and ‐resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B‐cell lymphoma](https://scholariq.org/papers/ofatumumab-demonstrates-activity-against-rituximab-sensitive-and-resistant-cell/)
- [Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma](https://scholariq.org/papers/regulation-of-cd20-in-rituximab-resistant-cell-lines-and-b-cell-non-hodgkin/)
- [Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas](https://scholariq.org/papers/distinct-cellular-and-therapeutic-effects-of-obatoclax-in-rituximab-sensitive/)
- [Myopia progression after cessation of atropine in children: a systematic review and meta-analysis](https://scholariq.org/papers/myopia-progression-after-cessation-of-atropine-in-children-a-systematic-review/)
- [Systematic Review of Myopia Progression after Cessation of Optical Interventions for Myopia Control](https://scholariq.org/papers/systematic-review-of-myopia-progression-after-cessation-of-optical-interventions/)
- [The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance](https://scholariq.org/papers/the-adhesion-molecule-icam-1-in-diffuse-large-b-cell-lymphoma-post-rituximab-era/)
- [Activity of ofatumumab (OFA), a fully human monoclonal antibody targeting CD20, against rituximab (RTX)-sensitive (RSCL) and rituximab-resistant cell lines (RRCL), in vivo, and primary tumor cells derived from patients with B-cell lymphoma.](https://scholariq.org/papers/activity-of-ofatumumab-ofa-a-fully-human-monoclonal-antibody-targeting-cd20/)
- [Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)](https://scholariq.org/papers/ofatumumab-a-fully-human-monoclonal-antibody-targeting-cd20-demonstrates/)
- [Revealing distinct treatment mechanisms and outcome correlations in patients with interstitial cystitis/bladder pain syndrome after different bladder therapies through urinary biomarker analysis](https://scholariq.org/papers/revealing-distinct-treatment-mechanisms-and-outcome-correlations-in-patients/)
- [Impact of orthokeratology and low‐dose atropine on corneal biomechanics and myopia progression in children](https://scholariq.org/papers/impact-of-orthokeratology-and-low-dose-atropine-on-corneal-biomechanics-and/)
- [Femtosecond laser-assisted cataract surgery versus conventional phacoemulsification cataract surgery: a meta-analysis of randomized controlled trials](https://scholariq.org/papers/femtosecond-laser-assisted-cataract-surgery-versus-conventional-2/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Tzu Chi University](https://scholariq.org/institutions/tzu-chi-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.